O-001
Actividad IN VITRO de Daptomicina combinada con ceftarolina o FOSFOMICINA FRENTE a Enterococcus faecalis sensible o RESISTENTE a la daptomicina
Leído
1710
Vecesse ha leído el artículo
685
Total PDF
1025
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 7 | 8 | 15 |
| 2025 11 | 32 | 41 | 73 |
| 2025 10 | 15 | 12 | 27 |
| 2025 9 | 18 | 22 | 40 |
| 2025 8 | 23 | 18 | 41 |
| 2025 7 | 26 | 16 | 42 |
| 2025 6 | 24 | 14 | 38 |
| 2025 5 | 22 | 9 | 31 |
| 2025 4 | 17 | 11 | 28 |
| 2025 3 | 23 | 14 | 37 |
| 2025 2 | 19 | 12 | 31 |
| 2025 1 | 14 | 9 | 23 |
| 2024 12 | 15 | 8 | 23 |
| 2024 11 | 20 | 8 | 28 |
| 2024 10 | 14 | 8 | 22 |
| 2024 9 | 24 | 21 | 45 |
| 2024 8 | 19 | 16 | 35 |
| 2024 7 | 18 | 9 | 27 |
| 2024 6 | 19 | 13 | 32 |
| 2024 5 | 14 | 16 | 30 |
| 2024 4 | 23 | 15 | 38 |
| 2024 3 | 14 | 13 | 27 |
| 2024 2 | 15 | 9 | 24 |
| 2024 1 | 12 | 12 | 24 |
| 2023 12 | 17 | 19 | 36 |
| 2023 11 | 14 | 4 | 18 |
| 2023 10 | 9 | 13 | 22 |
| 2023 9 | 10 | 9 | 19 |
| 2023 8 | 18 | 14 | 32 |
| 2023 7 | 15 | 6 | 21 |
| 2023 6 | 4 | 2 | 6 |
| 2023 5 | 19 | 3 | 22 |
| 2023 4 | 38 | 2 | 40 |
| 2023 3 | 12 | 1 | 13 |
| 2023 2 | 4 | 2 | 6 |
| 2022 1 | 9 | 3 | 12 |
| 2022 12 | 13 | 7 | 20 |
| 2022 11 | 11 | 18 | 29 |
| 2022 10 | 18 | 12 | 30 |
| 2022 9 | 12 | 16 | 28 |
| 2022 8 | 14 | 14 | 28 |
| 2022 7 | 12 | 6 | 18 |
| 2022 6 | 16 | 8 | 24 |
| 2022 5 | 13 | 7 | 20 |
| 2022 4 | 12 | 5 | 17 |
| 2022 3 | 20 | 6 | 26 |
| 2022 2 | 22 | 6 | 28 |
| 2021 1 | 10 | 9 | 19 |
| 2021 12 | 17 | 6 | 23 |
| 2021 11 | 13 | 9 | 22 |
| 2021 10 | 16 | 11 | 27 |
| 2021 9 | 14 | 9 | 23 |
| 2021 8 | 12 | 5 | 17 |
| 2021 7 | 13 | 9 | 22 |
| 2021 6 | 6 | 8 | 14 |
| 2021 5 | 8 | 10 | 18 |
| 2021 4 | 26 | 33 | 59 |
| 2021 3 | 14 | 9 | 23 |
| 2021 2 | 16 | 9 | 25 |
| 2020 1 | 12 | 9 | 21 |
| 2020 12 | 8 | 7 | 15 |
| 2020 11 | 6 | 3 | 9 |
| 2020 10 | 14 | 9 | 23 |
| 2020 9 | 26 | 9 | 35 |
| 2020 8 | 15 | 4 | 19 |
Mostrar todo
